Clinical Trials Directory

Trials / Terminated

TerminatedNCT00889512

The Luveris In Vitro Fertilization Trial

The Luveris® In Vitro Fertilization Trial: The Effect of Recombinant Luteinizing Hormone on Follicular Response, Oocyte Quality, and Pregnancy in In-Vitro Fertilization Treatment Cycles in Women Without Endogenous LH Activity.

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
14 (actual)
Sponsor
University Reproductive Associates · Academic / Other
Sex
Female
Age
18 Years – 38 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to develop a new protocol using two different types of fertility drugs that is more similar to the way the hormones act in a normal menstrual cycle (period). We are recruiting women who are trying to get pregnant through In Vitro Fertilization (IVF) who either have a high prolactin level (a hormone normally found in your blood that is produced in the brain) or have a condition known as hypothalamic amenorrhea in which one does not get regular periods due to low hormone levels. The ovaries can be stimulated with Follicle Stimulating Hormone (FSH) alone and with FSH and Luteinizing Hormone (LH). FSH causes eggs to be made while LH causes estrogen (hormone) production. The women in this study have low hormone levels and need both FSH and LH. Luveris® (LH hormone) is a new drug approved for egg production and is used in IVF. There is no set amount of LH nor a set protocol for LH use. Therefore, we are testing this new regimen. One group of women will receive a fixed dose of LH throughout their cycle while the other will decrease the dose of FSH while at the same time increasing the LH dose which is what happens in the natural menstrual cycle.

Conditions

Interventions

TypeNameDescription
DRUGLuveris fixed doseLuveris 75IU daily throughout ovarian stimulation
DRUGLuveris increasing doseLuveris 75IU until estradiol level reaches 250 pg/ml then increasing to 75IU BID for two days, then TID until hCG

Timeline

Start date
2009-04-01
Primary completion
2013-05-01
Completion
2013-11-01
First posted
2009-04-29
Last updated
2018-08-07
Results posted
2014-10-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00889512. Inclusion in this directory is not an endorsement.